{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Glaukos Corporation"},"Symbol":{"label":"Symbol","value":"GKOS"},"Address":{"label":"Address","value":"229 AVENIDA FABRICANTE, SAN CLEMENTE, California, 92672, United States"},"Phone":{"label":"Phone","value":"+1 949 367-9600"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure."},"CompanyUrl":{"label":"Company Url","value":"https://www.glaukos.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jay L. Katz","title":"Chief Medical Officer"},{"name":"Joseph E. Gilliam","title":"President & Chief Operating Officer"},{"name":"Thomas William Burns","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}